Real‐world experience of ocrelizumab in multiple sclerosis in a Spanish population

OBJECTIVE: Pivotal trial have shown that patients with multiple sclerosis (MS) receiving ocrelizumab had better outcomes. However, data on ocrelizumab in clinical practice are limited. The aim of this study was to evaluate the preliminary safety profile and effectiveness of ocrelizumab treatment for...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Ann Clin Transl Neurol
Asıl Yazarlar: Fernandez‐Diaz, Eva, Perez‐Vicente, Jose A., Villaverde‐Gonzalez, Ramon, Berenguer‐Ruiz, Leticia, Candeliere Merlicco, Antonio, Martinez‐Navarro, Maria Luisa, Gracia Gil, Julia, Romero‐Sanchez, Carlos M., Alfaro‐Saez, Arantxa, Diaz, Inmaculada, Gimenez‐Martinez, Juana, Mendez‐Miralles, Maria Angeles, Millan‐Pascual, Jorge, Jimenez‐Pancho, Javier, Mola, Santiago, Sempere, Angel P.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: John Wiley and Sons Inc. 2020
Konular:
Research Articles
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC7886031/
https://ncbi.nlm.nih.gov/pubmed/33369288
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/acn3.51282
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller